newsfilter
← Latest News
GlobeNewswire·

Aravive Reports Third Quarter 2021 Financial Results and Provides Corporate Updates

Dosed first patient in batiraxcept (formerly AVB-500) Phase 1b clinical trial in pancreatic adenocarcinoma Orphan drug designation granted by European Commission to batiraxcept in platinum resistant ovarian cancer New preliminary data from batiraxcept